Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 12/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 8/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.37 |
| ▸ | CHRNA2 | Q15822 | 5/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.37 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.30 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6231761 | 0.96 | CHRNB2 (0.40) | CHRNB2CHRNA3CHRNA4CHRNA2CHRNB4 | |
| SCHEMBL5802609 | 0.85 | FKBP1A (0.36) | CHRNB2 | |
| SCHEMBL6233687 | 0.81 | CHRNB2 (0.56) | CHRNB2CHRNA3CHRNA4CHRNA2CHRNB4 | |
| SCHEMBL8149383 | 0.80 | CHRNB2 (0.46) | CHRNB2CHRNA3CHRNA4CHRNA2CHRNB4 | |
| SCHEMBL6273656 | 0.80 | CHRNB2 (0.46) | CHRNB2CHRNA3CHRNA4CHRNA2CHRNB4 | |
| SCHEMBL8506415 | 0.80 | CHRNB2 (0.46) | CHRNB2CHRNA3CHRNA4CHRNA2CHRNB4 | |
| SCHEMBL2498122 | 0.75 | CHRNA3 (0.51) | CHRNB2CHRNA3CHRNA4CHRNA2CHRNB4 | |
| SCHEMBL2500469 | 0.75 | CHRNB2 (0.46) | CHRNB2CHRNA3CHRNA4CHRNA2CHRNB4 | |
| SCHEMBL8911083 | 0.72 | MMP13 (0.38) | — | |
| SCHEMBL5806257 | 0.71 | NPC1 (0.35) | CHRNB2CHRNA3CHRNA4CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005000806-A2 | LIGANDS FOR NICOTINIC ACETYLCHOLINE RECEPTORS, AND METHODS OF MAKING AND USING THEM | GEORGETOWN UNIVERSITY (US) | 2005-01-06 | — | — | WO | disclosed |